Skip to main content
. Author manuscript; available in PMC: 2019 Jul 17.
Published in final edited form as: Med Decis Making. 2018 Apr;38(1 Suppl):32S–43S. doi: 10.1177/0272989X17743236

Figure 1.

Figure 1

Timeline showing when screening mammography and different types of treatment became widespread in the general population compared to data available in the Surveillance Epidemiology and End Results (SEER) registry and incidence records with screening histories provided by the Breast Cancer Surveillance Consortium (BCSC). * Estrogen-receptor (ER) status and human epidermal growth factor 2 (HER2) status were available in the Breast Cancer Surveillance Consortium (BCSC) data for women diagnosed between 1996–2010 and 1999–2010, respectively.